Insufficient scRNA-seq data for expression of ZDHHC8 at single-cell level.
Insufficient scRNA-seq data for expression of ZDHHC8 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 3317.73 | 1445 / 1445 | 100% | 40.10 | 183 / 183 |
brain | 100% | 3675.38 | 2635 / 2642 | 100% | 31.71 | 705 / 705 |
pancreas | 100% | 2603.39 | 328 / 328 | 99% | 26.54 | 177 / 178 |
prostate | 100% | 3952.07 | 245 / 245 | 99% | 21.70 | 499 / 502 |
skin | 100% | 4300.45 | 1808 / 1809 | 99% | 43.36 | 469 / 472 |
ovary | 100% | 4278.09 | 180 / 180 | 99% | 30.97 | 427 / 430 |
thymus | 100% | 5039.67 | 653 / 653 | 99% | 26.01 | 600 / 605 |
uterus | 100% | 4661.12 | 170 / 170 | 99% | 26.09 | 453 / 459 |
kidney | 100% | 3561.70 | 89 / 89 | 99% | 24.58 | 888 / 901 |
lung | 100% | 4168.18 | 577 / 578 | 98% | 29.02 | 1132 / 1155 |
adrenal gland | 100% | 3819.88 | 258 / 258 | 98% | 35.15 | 225 / 230 |
bladder | 100% | 3512.38 | 21 / 21 | 98% | 29.05 | 493 / 504 |
intestine | 100% | 3108.77 | 966 / 966 | 98% | 24.18 | 515 / 527 |
stomach | 100% | 2707.36 | 359 / 359 | 98% | 26.69 | 279 / 286 |
breast | 100% | 4268.48 | 459 / 459 | 95% | 17.43 | 1066 / 1118 |
liver | 100% | 2446.35 | 226 / 226 | 77% | 10.58 | 312 / 406 |
adipose | 100% | 4281.48 | 1204 / 1204 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 100% | 35.01 | 80 / 80 |
spleen | 100% | 4876.04 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 20.78 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 35.38 | 1 / 1 |
blood vessel | 100% | 3239.96 | 1333 / 1335 | 0% | 0 | 0 / 0 |
heart | 100% | 2713.45 | 859 / 861 | 0% | 0 | 0 / 0 |
muscle | 98% | 1668.38 | 788 / 803 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 93% | 19.77 | 27 / 29 |
peripheral blood | 77% | 1208.79 | 711 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_1903078 | Biological process | positive regulation of protein localization to plasma membrane |
GO_0018345 | Biological process | protein palmitoylation |
GO_0034380 | Biological process | high-density lipoprotein particle assembly |
GO_0018230 | Biological process | peptidyl-L-cysteine S-palmitoylation |
GO_0044794 | Biological process | positive regulation by host of viral process |
GO_0010875 | Biological process | positive regulation of cholesterol efflux |
GO_0007626 | Biological process | locomotory behavior |
GO_0031966 | Cellular component | mitochondrial membrane |
GO_0000139 | Cellular component | Golgi membrane |
GO_0005829 | Cellular component | cytosol |
GO_0005794 | Cellular component | Golgi apparatus |
GO_0016409 | Molecular function | palmitoyltransferase activity |
GO_0019706 | Molecular function | protein-cysteine S-palmitoyltransferase activity |
Gene name | ZDHHC8 |
Protein name | ZDHHC8 protein Palmitoyltransferase (EC 2.3.1.225) Palmitoyltransferase ZDHHC8 (EC 2.3.1.225) (Zinc finger DHHC domain-containing protein 8) (DHHC-8) (Zinc finger protein 378) |
Synonyms | ZDHHCL1 ZNF378 KIAA1292 |
Description | FUNCTION: Palmitoyltransferase that catalyzes the addition of palmitate onto various protein substrates and therefore functions in several unrelated biological processes (Probable). Through the palmitoylation of ABCA1 regulates the localization of the transporter to the plasma membrane and thereby regulates its function in cholesterol and phospholipid efflux (Probable). Could also pamitoylate the D(2) dopamine receptor DRD2 and regulate its stability and localization to the plasma membrane (Probable). Could also play a role in glutamatergic transmission (By similarity). .; FUNCTION: (Microbial infection) Able to palmitoylate SARS coronavirus-2/SARS-CoV-2 spike protein following its synthesis in the endoplasmic reticulum (ER). In the infected cell, promotes spike biogenesis by protecting it from premature ER degradation, increases half-life and controls the lipid organization of its immediate membrane environment. Once the virus has formed, spike palmitoylation controls fusion with the target cell. . |
Accessions | Q9ULC8 Q96GI9 C9JVM2 ENST00000320602.11 [Q9ULC8-2] ENST00000436518.5 ENST00000334554.12 [Q9ULC8-1] ENST00000405930.3 [Q9ULC8-3] |